| REVIEW ARTICLE |
|
| Year : 2012 | Volume
: 7
| Issue : 5 | Page : 80-86 |
|
|
Juvenile dermatomyositis: A review of clinical features and management
S Habibi1, AV Ramanan2
1 Department of Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad, India
2 Department of Paediatric Rheumatology, Bristol Royal Hospital for Children and Royal National Hospital for Rheumatic Diseases, UK
Correspondence Address:
S Habibi
Department of Rheumatology, Nizam's Institute of Medical Sciences, Hyderabad, India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.1016/S0973-3698(12)60032-6
|
|
|
Juvenile dermatomyositis is the most common of the idiopathic inflammatory myositis of childhood. It is characterised by a pathognomic skin rash along with proximal muscle weakness. It may also affect organs other than the muscle and skin. Calcinosis and lipodystrophy are complications of long-standing untreated or poorly treated disease, asso- ciated with chronic morbidity. A variety of environmental and genetic risk factors are implicated in its pathogenesis. Up-regulation of genes by type-I interferon appears central. Corticosteroids along with methotrexate are the mainstay of therapy. Disease outcome is in general good.
|
|
|
|
| [PDF]* |
|
 |
|
